MASUROTA ® is a patented food supplement based on high-doseof probiotics (25 billion live cells and 50 billion live cells) formulated by Deltha Pharma clinical research in collaboration with the Università Cattolica del Sacro Cuore - Policlinico Agostino Gemelli in Rome. It is indicated for the correct functionality and for the balance of the intestinal bacterial flora.
- Consortium of high-dose probiotics (9 selected strains and two distinct formulations: 25 and 50 billion of live cells)
- Clinical research and patent of the Università Cattolica del Sacro Cuore - Policlinico Agostino Gemelli in Rome with a unique and innovative formulation to correct dysbiosis and support the natural balance of the intestinal bacterial flora
- Packaged in transparent, vegetable and gastro-resistant capsules:
- Masking of unpleasant taste and odor
- No brighteners (titanium dioxide)
- Maintaining the viability and efficacy of probiotics in the gastrointestinal tract
|Average contain for capsule||MASUROTA 25 MLD||MASUROTA 50 MLD|
|Bifidobacterium longum||5,4 bilion||10,8 bilion|
|Bacillus subtilis||2,3 bilion||4,6 bilion|
|Streptococcus thermophilus||2,7 bilion||5,4 bilion|
|Bifidobacterium bifidum||2,95 bilion||5,9 bilion|
|Bifidobacterium breve||2,8 bilion||5,6 bilion|
|Enterococcus fecium||2,75 bilion||5,5 bilion|
|Lactobacillus gasseri||0,98 bilion||1,96 bilion|
|Lactobacillus casei||1,4 bilion||2,8 bilion|
|Lactobacillus rhamnosus||1,4 bilion||2,8 bilion|
|Inulina||268 mg||536 mg|
Probiotics (pro-bios: in favor of life) are "live micro-organisms that, administered in adequate quantities, bring a benefit to the health of the host" and their use dates back to the early twentieth century. To be defined probiotic, a microorganism must have very specific characteristics:
- Being normally present in our bowel, not giving allergic or otherwise harmful reactions;
- Belong to the list of bacterial species qualified presumably as safe by EFSA. In any case, probiotic microorganisms must not be carriers of acquired and / or transmissible antibiotic resistance;
- Be active, persistent (able to adhere to the intestinal walls and of bowel colonization) and vital (able to reproduce) in quantities that justify any beneficial effects observed in efficacy studies;
- Be able to confer a proven physiological benefit (FAO / WHO document on the evaluation of probiotics for food use).
MASUROTA ® is packaged in transparent, vegetable and gastro-resistant capsules (DRcaps). In this way the use of brighteners (titanium dioxide) has been avoided. The capsules are suitable for vegetarians and are Halal and Kosher certified. DRcaps technology also allows the masking of unpleasant smells or flavors and protects probiotics from gastric acidity, ensuring their arrival alive and vital in the intestinal tract, with the maintenance of efficacy.
MASUROTA ® promotes the maintenance of the intestinal microbiota balance and is a valid help in case of dysbiosis.
Bifidobacteria are among the main constituents of the human intestinal microbiota and have been known since 1899. They have a rod shape and are capable of fermenting oligosaccharides. Their presence promotes the intestinal flora balance and hinders the growth of pathogens such as Escherichia coli both for nutrients competition and for the lactic acid production. They have also an immunostimulant activity. Various authors have shown their role in conditions such as poor digestion, diarrhea and constipation in adults and children.
Lactobacilli are among the most studied probiotics. They are widely present in the gastrointestinal tract and in the vagina and ferment lactose and other sugars with the production of lactic acid and various secondary compounds (acetic acid, ethanol, carbon dioxide ..) reducing the pH and thus contrasting the growth of species such as Candida albicans. They are also useful in case of lactose intolerance, in decreasing the production of gas due to the consumption of legumes, in strengthening the intestinal barrier andin producing bactericidal substances. They stimulate the local immune system promoting IgA production, they have also shown beneficial effects in intestinal inflammatory diseases and in case of diarrhea.
Enterococcus faecium is widely present in the intestine and in the environment thanks to its remarkable survival capabilities. It has been shown to hinder the growth of pathogenic organisms such as Escherichia coli, Salmonella, Shigella and Enterobacter spp and to be useful in cases of antibiotic-related and infectious diarrhea.
Streptococcus termophilus is classified as a lactic bacterium, it is present in the intestinal environment and in milk. It is industrially used in the dairy industry for the production of cheeses such as mozzarella, asiago, gruyere, for example. It produces exopolysaccharides which have been attributed antibacterial and antioxidant, immunostimulant and regenerative properties for the mucosa.
Bacillus subtilis is widely used for the proteolysis and fermentation capacity of foods based on cereals, corn and legumes (Latin America, Africa), rice and fish (Asia) which result improved from an organoleptic point of view and enriched in proteins. It is also used in agriculture to enrich the soil and as a microorganism "model" in research laboratories, given its handling and ease of use. As a direct use for humans, Bacillus subtilis has been historically used in the treatment of gastrointestinal and urinary tract diseases, thanks to its immunostimulating properties, in the pre-antibiotic era: its presence is in fact cable to inducethe production of antibodies (IgM, IgG, IgA), cytokines and stimulating leukocytes, and for this reasosn it was marketed in America and Europe for such uses in 1946. It has also showed activity against Escherichia coli.
Inulin is a fiber composed of units of fructose used by the Composites as reserveof energy. It is mainly extracted from the chicory roots and is classified as a prebiotic: "non-digestible substance of food origin that can selectively promote the growth and / or activity of one or more bacteria in the intestinal tract". It also improves intestinal regularity. As for its prebiotic activity, Inulin undergoes fermentation at the intestinal level, resulting in lactic acid and short chain fatty acids (SCFAs: acetic acid, propionate and butyrate) production, which hinder the growth of pathogenic species whichhave antiputrefactive activity and they arebeneficial for enterocytes with improvement of the absorption and integrity of the mucous membranes.